explore -WSS

explore

author：hotspot 2025-10-04 11:35:26 - browse：68

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The problem with charging patients to message their doctors

hotspot

WSS

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A look at other Americans who have crossed into North Korea over the years

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

With psoriasis trial ahead, Alumis raises $259 million

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

15 die by electrocution after transformer explodes in northern India

focus

explore

Wikipedia

How to save PrEP access — and even expand it

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Bright Health sells Medicare Advantage business to Molina

ER docs worry over extreme heat as a 'mass casualty event'

Bright Health sells Medicare Advantage business to Molina

House passes resolution saying Israel isn't a 'racist or apartheid state'

State Dept. review finds Biden bears some blame for Afghanistan failures

Johnson & Johnson sues to stop Medicare negotiation

Heart attack and stroke risk calculators need revising

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

entertainment

Novo Nordisk obesity pill bests Wegovy in early trial

The drug industry has found itself all alone in Washington

IVF, abortion rights issues kick off Biden’s State of the Union

The drug industry has found itself all alone in Washington

A deep dive into Applied Therapeutics’ data, and questions on Cassava

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Wikipedia

entertainment

hotspot

hotspot